Moves by the European Commission to allow drug companies to use the television, radio, and print media to provide information on prescription drugs to consumers throughout Europe are being strongly criticised by medical and consumer organisations.

As the two month public consultation on possible changes to existing European legislation ended on Monday, opponents warned that the initiative failed to make a clear distinction between information and advertising; would drive up public health costs; and could endanger patients’ health.

The criticism came from a group of 11 health organisations that represent doctors, insurance organisations, pharmacists, and patients as well …